Citation: Rp. Wernyj et al., Multiple Antibodies to Titin Immunoreact With AHNAK and Localize to the Mitotic Spindle Machinery, CELL MOTIL, 50(2), 2001, pp. 101-113
Authors:
Zheng, SL
Xu, JF
Isaacs, SD
Wiley, K
Chang, BL
Bleecker, ER
Walsh, PC
Trent, JM
Meyers, DA
Isaacs, WB
Citation: Sl. Zheng et al., Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families, HUM GENET, 108(5), 2001, pp. 430-435
Authors:
Xu, JF
Zheng, SL
Chang, BL
Smith, JR
Carpten, JD
Stine, OC
Isaacs, SD
Wiley, KE
Henning, L
Ewing, C
Bujnovszky, P
Bleeker, ER
Walsh, PC
Trent, JM
Meyers, DA
Isaacs, WB
Citation: Jf. Xu et al., Linkage of prostate cancer susceptibility loci to chromosome 1, HUM GENET, 108(4), 2001, pp. 335-345
Authors:
Luo, J
Duggan, DJ
Chen, YD
Sauvageot, J
Ewing, CM
Bittner, ML
Trent, JM
Isaacs, WB
Citation: J. Luo et al., Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling, CANCER RES, 61(12), 2001, pp. 4683-4688
Authors:
Nelson, CP
Kidd, LCR
Sauvageot, J
Isaacs, WB
De Marzo, AM
Groopman, JD
Nelson, WG
Kensler, TW
Citation: Cp. Nelson et al., Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1, CANCER RES, 61(1), 2001, pp. 103-109
Authors:
Lin, XH
Tascilar, M
Lee, WH
Vles, WJ
Lee, BH
Veeraswamy, R
Asgari, K
Freije, D
van Rees, B
Gage, WR
Bova, GS
Isaacs, WB
Brooks, JD
DeWeese, TL
De Marzo, AM
Nelson, WG
Citation: Xh. Lin et al., GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells, AM J PATH, 159(5), 2001, pp. 1815-1826
Authors:
Xu, JF
Zheng, SQL
Hawkins, GA
Faith, DA
Kelly, B
Isaacs, SD
Wiley, KE
Chang, BL
Ewing, CM
Bujnovszky, P
Carpten, JD
Bleecker, ER
Walsh, PC
Trent, JM
Meyers, DA
Isaacs, WB
Citation: Jf. Xu et al., Linkage and association studies of prostate cancer susceptibility: Evidence for linkage at 8p22-23, AM J HU GEN, 69(2), 2001, pp. 341-350
Authors:
Xu, JF
Zheng, SQL
Carpten, JD
Nupponen, NN
Robbins, CM
Mestre, J
Moses, TY
Faith, DA
Kelly, BD
Isaacs, SD
Wiley, KE
Ewing, DM
Bujnowszky, P
Chang, BI
Bailey-Wilson, J
Bleecker, ER
Walsh, PC
Trent, JM
Meyers, DA
Isaacs, WB
Citation: Jf. Xu et al., Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer, AM J HU GEN, 68(4), 2001, pp. 901-911
Authors:
Shepard, TF
Platz, EA
Kantoff, PW
Nelson, WG
Isaacs, WB
Freije, D
Febbo, PG
Stampfer, MJ
Giovannucci, E
Citation: Tf. Shepard et al., No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: A prospective study, CANC EPID B, 9(11), 2000, pp. 1267-1268
Authors:
Wilkens, EP
Freije, D
Xu, JF
Nusskern, DR
Suzuki, H
Isaacs, SD
Wiley, K
Bujnovszky, P
Meyers, DA
Walsh, PC
Isaacs, WB
Citation: Ep. Wilkens et al., No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer, PROSTATE, 39(4), 1999, pp. 280-284
Authors:
Zhong, H
De Marzo, AM
Laughner, E
Lim, M
Hilton, DA
Zagzag, D
Buechler, P
Isaacs, WB
Semenza, GL
Simons, JW
Citation: H. Zhong et al., Overexpression of hypoxia-inducible factor 1 alpha in common human cancersand their metastases, CANCER RES, 59(22), 1999, pp. 5830-5835
Authors:
Kibel, AS
Schutte, M
Kern, SE
Isaacs, WB
Bova, GS
Citation: As. Kibel et al., Identification of 12p as a region of frequent deletion in advanced prostate cancer, CANCER RES, 58(24), 1998, pp. 5652-5655